Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 20:04:13 UTC |
---|
Update Date | 2021-09-24 20:04:14 UTC |
---|
HMDB ID | HMDB0304855 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Pralsetinib |
---|
Description | Based on a literature review very few articles have been published on (1r,4r)-N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)imino]-1,6-dihydropyrimidin-2-yl}cyclohexane-1-carboximidic acid. |
---|
Structure | CO[C@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1 InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(1R,4R)-N-[(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)imino]-1,6-dihydropyrimidin-2-yl}cyclohexane-1-carboximidate | Generator |
|
---|
Chemical Formula | C27H32FN9O2 |
---|
Average Molecular Weight | 533.612 |
---|
Monoisotopic Molecular Weight | 533.266299469 |
---|
IUPAC Name | (1r,4r)-N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide |
---|
Traditional Name | (1r,4r)-N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CO[C@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1 |
---|
InChI Identifier | InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27-/m0/s1 |
---|
InChI Key | GBLBJPZSROAGMF-BATDWUPUSA-N |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pralsetinib,1TMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 4481.8 | Semi standard non polar | 33892256 | Pralsetinib,1TMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 3899.1 | Standard non polar | 33892256 | Pralsetinib,1TMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 6128.3 | Standard polar | 33892256 | Pralsetinib,1TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 4771.3 | Semi standard non polar | 33892256 | Pralsetinib,1TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 4014.2 | Standard non polar | 33892256 | Pralsetinib,1TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 6520.3 | Standard polar | 33892256 | Pralsetinib,1TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 4702.7 | Semi standard non polar | 33892256 | Pralsetinib,1TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 3925.3 | Standard non polar | 33892256 | Pralsetinib,1TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 6661.4 | Standard polar | 33892256 | Pralsetinib,2TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 4416.4 | Semi standard non polar | 33892256 | Pralsetinib,2TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 3895.0 | Standard non polar | 33892256 | Pralsetinib,2TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C)=N2)CC1 | 5680.8 | Standard polar | 33892256 | Pralsetinib,2TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 4509.9 | Semi standard non polar | 33892256 | Pralsetinib,2TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 3962.3 | Standard non polar | 33892256 | Pralsetinib,2TMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 5845.8 | Standard polar | 33892256 | Pralsetinib,2TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 4664.3 | Semi standard non polar | 33892256 | Pralsetinib,2TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 3984.8 | Standard non polar | 33892256 | Pralsetinib,2TMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C)C(C)=C3)=N2)CC1 | 6080.7 | Standard polar | 33892256 | Pralsetinib,3TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 4470.4 | Semi standard non polar | 33892256 | Pralsetinib,3TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 3983.2 | Standard non polar | 33892256 | Pralsetinib,3TMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C)C(C)=C3)[Si](C)(C)C)=N2)CC1 | 5442.7 | Standard polar | 33892256 | Pralsetinib,1TBDMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4644.7 | Semi standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4107.3 | Standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #1 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 6079.6 | Standard polar | 33892256 | Pralsetinib,1TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 4891.7 | Semi standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 4231.7 | Standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 6398.6 | Standard polar | 33892256 | Pralsetinib,1TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 4854.9 | Semi standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 4164.6 | Standard non polar | 33892256 | Pralsetinib,1TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=N[NH]C(C)=C3)=N2)CC1 | 6608.7 | Standard polar | 33892256 | Pralsetinib,2TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4717.5 | Semi standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4312.9 | Standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=N[NH]C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 5651.0 | Standard polar | 33892256 | Pralsetinib,2TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4833.2 | Semi standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4372.4 | Standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #2 | CO[C@]1(C(=O)N[C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 5763.8 | Standard polar | 33892256 | Pralsetinib,2TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 4939.4 | Semi standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 4408.8 | Standard non polar | 33892256 | Pralsetinib,2TBDMS,isomer #3 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(NC3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)=N2)CC1 | 5971.6 | Standard polar | 33892256 | Pralsetinib,3TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4931.1 | Semi standard non polar | 33892256 | Pralsetinib,3TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 4582.6 | Standard non polar | 33892256 | Pralsetinib,3TBDMS,isomer #1 | CO[C@]1(C(=O)N([C@@H](C)C2=CC=C(N3C=C(F)C=N3)N=C2)[Si](C)(C)C(C)(C)C)CC[C@@H](C2=NC(C)=CC(N(C3=NN([Si](C)(C)C(C)(C)C)C(C)=C3)[Si](C)(C)C(C)(C)C)=N2)CC1 | 5437.1 | Standard polar | 33892256 |
|
---|